What is the generic name?

OMACETAXINE MEPESUCCINATE

What is the Trade Name for OMACETAXINE MEPESUCCINATE?

SYNRIBO

What are the Indications for OMACETAXINE MEPESUCCINATE?

• 1 INDICATIONS AND USAGE SYNRIBO is indicated for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI). SYNRIBO for Injection is indicated for the treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI) ( 1 ).

References: https://open.fda.gov/